Neuroprotection of the brain during cardiopulmonary bypass. A randomized trial of remacemide during coronary artery bypass in 171 patients

Stroke

Volumn 29, Issue 11, 1998, Pages 2357-2362

  Arrowsmith, J E ^a   Harrison, M J G ^a,b   Newman, S P ^a   Stygall, J ^a   Timberlake, N ^a   Pugsley, W B ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Bypass surgery; Neuroprotective agents; Neuropsychological tests; Ultrasonography, Doppler

Indexed keywords

REMACEMIDE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DOPPLER FLOWMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PEROPERATIVE CARE; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031729796     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.11.2357     Document Type: Article

References (16)

1. Siesjo BK. Pathophysiology and treatment of focal cerebral ischaemia. J Neurosurg. 1992;77:169-184, 337-354.
2. Ozyurt E, Graham DI, Woodruff GN, McCulloch J. Protective effect of the glutamate antagonist MK801 in focal cerebral ischaemia in the cat. J Cereb Blood Flow Metab. 1988;8:138-143.
3. Smith P, Treasure T, Newman S, Joseph P, Schneidau A, Ell PJ, Harrison MJG. Cerebral consequences of cardiopulmonary bypass. Lancet. 1986;1:823-825.
4. Pugsley W, Klinger L, Paschalis C, Aspey B, Newman S, Harrison M, Treasure T. Microemboli and cerebral impairment during cardiac surgery. Vasc Surg. 1990;24:34-43.
5. Shaw PJ, Bates D, Cartlidge NEF, Heaviside D, Julian DG, Shaw DA. Early neurological complications of coronary artery bypass surgery. Br Med J. 1985;1384-1387.
6. Blauth CI, Smith PL, Arnold JV, Jagoe JR, Wootton R, Taylor KM. Influence of oxygenator type on the prevalence and extent of microembolic ischaemia during cardiopulmonary bypass: assessment by digital image analysis. J Thorac Cardiovasc Surg. 1990;99:61-69.
7. Bannan PE, Graham DI, Lees KR, McCulloch J. Neuroprotective effect of remacemide hydrochloride in focal cerebral ischaemia in the cat. Brain Res. 1994;664:271-275.
8. Grieco G, d'Hollosy M, Culliford AT, Jonas S. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Stroke. 1996;27:858-874.
9. Newman SP, Klinger L, Venn GE, Smith PL, Harrison MJG, Treasure T. The persistence of neuropsychological deficits twelve months after coronary artery bypass surgery. In: Willner AE, Rodewald G, eds. Impact of Cardiac Surgery on the Quality of Life. New York, NY: Plenum Press; 1990:173-179.
10. Newman S. Neuropsychological and psychological changes. In: Smith P, Taylor K, eds. Cardiac Surgery and the Brain. London, UK: Edward Arnold Publishers Ltd; 1993:34-54.
11. Stump, D. Selection and clinical significance of neuropsychologic tests. Ann Thorac Surg. 1995;59:1340-1344.
12. Pugsley W, Klinger L, Paschalis et al. The impact of microemboli in cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994;25:1393-1399.
13. Newman S. Analysis and interpretation of neuropsychologic tests in cardiac surgery. Ann Thorac Surg. 1995;59:1351-1355.
14. Murkin JM, Newman SP, Stump DA, Blumenthal JA. Statement of consensus on assessment of neurobehavioural outcomes following cardiac surgery. Ann Thorac Surg. 1995;59:1289-1295.
15. Carlson R. Conflicting results with lubeluzole in stroke. Inpharma. 1997; 1027:9.
16. Diener HC, Hacke W, Hennerici M, Radberg J, Hamlson L, De Kayser J. Lubeluzole in acute ischaemic stroke. Stroke. 1996;27:76-81.